[Candida].

I Furuta

Home/Archive/PubMed

PubMed · 11132558

[Candida].

I Furuta

View original source ↗Export metadata ↓

Abstract

The incidence of candidiasis has steadily increased with the number of patients with opportunistic infection. Candidiasis is often observed in patients with leukemia, malignant lymphoma and aplastic anemia, all of whom show immunodeficiency. Factors contributing to the increased incidence of candida infections include the overuse of broad-spectrum antimicrobial agents, and the prolonged survival of patients with immunodeficiency. Candida is a major causative organism of nosocomial infection, as are P. aeruginosa and methicillin-resistant Staphylococcus aureus. The number isolated was greater in the order of C. albicans > C. glabrata > C. tropicalis > C. parapsilosis > C. krusei. C. albicans, which was detected most frequency, was isolated from 60-70% of all samples every year. Isolated frequencies of C. albicans were 66-77% from sputum, 43-70% from urine, and 62-72% from vaginal swabs. In regard to annual changes in deep-seated candidiasis among autopsied cases, the incidence reached a peak in the 1985 to 1988 period, and thereafter decreased. The number of cases with infection of the stomach was largest, followed by the esophagus, the lung and kidney. These cases with deep-seated candidiasis showed low values or levels of lymphocyte, neutrophil, hemoglobin, hemoglobin total protein and total cholesterol.

Explore related subjects

Candida Candidiasis Cross Infection Hematologic Neoplasms Humans Immunocompromised Host Opportunistic Infections Risk Factors Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

I Furuta. 2000. [Candida].. https://pubmed.ncbi.nlm.nih.gov/11132558/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Metabolic engineering of Candida yeasts for biotechnological applications.

Candida yeasts represent a versatile yet underexploited platform for industrial biotechnology. These yeasts utilize a remarkably broad range of carbon sources, particularly for hydrophobic carbon sources, coupled with robust growth and diverse biosynthetic capacities, making them promising hosts for sustainable production of chemicals, fuels, and proteins. Despite these advantages, industrial deployment of Candida species has been hindered by concerns regarding opportunistic pathogenicity and the historical lack of efficient genetic manipulation tools, leading to a substantial gap between metabolic potential and practical utilization. Recent advances in functional genomics, genome editing, and systems metabolic engineering are rapidly overcoming these barriers, enabling more precise and efficient strain development. In this review, we systematically summarize recent progress in the metabolic engineering of Candida species as microbial cell factories, with particular emphasis on expanding genetic toolkits, utilizting renewable and non-conventional carbon sources, and biosynthesizing high-value compounds. In addition, we propose a biosafety-oriented classification framework to support their safe industrial deployment. Finally, we discuss current challenges and emerging opportunities, emphasizing that the synergy of synthetic biology and artificial intelligence-driven design holds the key to unlocking the biotechnological potential of Candida yeasts.

Candida↗

PubMed2002

Identification of cultured isolates of clinically important yeast species using fluorescent fragment length analysis of the amplified internally transcribed rRNA spacer 2 region (ITS2).

BACKGROUND: The number of patients candidate to yeast infection has increased during the last years. Also the variety of species of clinical importance has increased. Correct species identification is often important for efficient therapy, but is based on phenotypic features and is sometimes time-consuming and depends largely on the expertise of technicians. Therefore, we evaluated the feasability of PCR-based amplification of the Internally Transcribed Spacer region 2, followed by fragment size analysis on the ABI Prism 310 for the identification of clinically important yeasts. RESULTS: A rapid DNA-extraction method, based on simple boiling freezing was introduced. Of the 25 species tested, 22 could be identified unambiguously by scoring the length of the ITS2-region. No distinction could be made between the species T. asteroides and T. inkin and between T. mucoides and T. ovoides. The two varieties of Cryptococcus neoformans (var. neoformans and var. gattii) could be differentiated from each other due to a one bp length difference of the ITS2 fragment. The three C. laurentii isolates were split in two groups according to their ITS2-fragment lengths, in correspondence with the phylogenetic groups described previously. Since the obtained fragment lenghts compared well to those described previously, an internationally usable library of ITS2 fragment lengths can be constructed. CONCLUSIONS: The existing ITS2 size based library enables identification of most of the clinically important yeast species, within 6 hours starting from a single colony, can be easily updated when new species are described. Data can be exchanged between laboratories.

Candida↗

PubMed2002

Enantiomeric resolution of 2-aryl propionic esters with hyperthermophilic and mesophilic esterases: contrasting thermodynamic mechanisms.

The enantiomeric resolution of 2-aryl propionic esters by hyperthermophilic and mesophilic esterases was found to be governed by contrasting thermodynamic mechanisms. Entropic contributions predominated for mesophilic esterases from Candida rugosa and Rhizomucor miehei, while enthalpic forces controlled this resolution by the esterase from the extremely thermoacidophilic archaeon, Sulfolobus solfataricus P1. This disparity in thermodynamic mechanism can be attributed to the differences in conformational flexibility of mesophilic and thermophilic enzymes as they relate to the temperature range (4-70 degrees C) examined.

Candida↗